The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 16, 2016
Filed:
Mar. 17, 2010
Luis Alejandro Barrera, Puerto, CO;
Eduardo Egea, Puerto, CO;
Johana Espejo, Puerto, CO;
Catalina Sosa, Puerto, CO;
Elkin Navarro, Puerto, CO;
Gloria Garavito, Barranquilla, CO;
Dary Luz Mendoza, Barranquilla, CO;
Leonardo Lareo, Puerto, CO;
Luis Miguel Renjifo Martinez, Bogotá, CO;
Luis Alejandro Barrera, Puerto, CO;
Eduardo Egea, Puerto, CO;
Johana Espejo, Puerto, CO;
Catalina Sosa, Puerto, CO;
Elkin Navarro, Puerto, CO;
Gloria Garavito, Barranquilla, CO;
Dary Luz Mendoza, Barranquilla, CO;
Leonardo Lareo, Puerto, CO;
FUNDACION UNIVERSIDAD DEL NORTE, Barranquilla, CO;
PONTIFICIA UNIVERSIDAD JAVERIANA, Bogota, CO;
Abstract
The invention refers to the design, synthesis and evaluation of 6 synthetic oligopeptides, that have not been previously described, designed from the T and B epitopes of allergens of group I of intradomiciliary mites of the speciesand, which can be used in the immunomodulation of individuals having immunocompetent systems and in the production of IgY polyclonal antibodies. The invention relates to a first method for obtaining a composition of IgY polyclonal antibodies that can be used as a diagnostic reagent having low cost and high reactivity in respect of intradomiciliary mites, and a second method for the detection of mite allergens, using the IgY antibody composition developed in the first method. The invention further relates to the composition of the IgY polyclonal antibodies.